A Vancouver pharmacist, Geoffrey Kyle Soo Chan, has been suspended for six months and fined $20,000 after admitting to professional misconduct involving the distribution of over 28,000 doses of naloxone nasal spray to a single individual. The decision, outlined in a consent order by the College of Pharmacists of B.C., also requires Chan to complete remedial training.
Between January 1 and August 31, 2021, Chan, manager of Pharmachoice Main on Main Street, processed 1,646 transactions involving 28,404 doses of naloxone using the personal health information of 301 patients from communities across British Columbia. All doses were ultimately provided to one individual claiming to act as a “patient representative.”
The consent order highlights that Chan did not obtain patient consent, a violation of the pharmacy profession’s code of ethics. He also failed to verify the identity of patients or their representative before accessing and using personal health information, a critical breach of professional and legal standards.
According to the agreement, Chan neglected to prioritize the health and well-being of the patients, failed to exercise professional judgment, and did not inform patients of the benefits and risks associated with naloxone nasal spray.
As part of his suspension, effective December 3, Chan must review relevant laws and ethical standards, complete remedial courses, and submit a written reflection on his learnings to the College of Pharmacists of B.C.
This case underscores the importance of adherence to ethical and professional standards in healthcare, particularly when handling sensitive medications and patient information.
